Xtandi 80 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FHVQH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,170
Award facts
- Contract value 100% obligated
- $4,169.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,169.59 by the Defense Logistics Agency on July 14, 2025, for the supply of Xtandi 80 mg tablets (60-count units). This firm fixed-price delivery order, which is expected to be completed by July 15, 2025, represents a discrete fulfillment under the company's larger Indefinite Delivery Contract with DLA. The award carries no set-aside designation, reflecting DMS Pharmaceutical Group's competitive position in federal procurement markets. The place of performance is located in Park Ridge, Illinois, where the company maintains its operational headquarters.
This delivery order falls under DMS Pharmaceutical Group's $499.999 billion single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valid through November 2026. The contract vehicle enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide. Xtandi, an oncology treatment medication, represents one of many branded pharmaceutical products the company supplies to military health facilities. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group continues to provide direct distribution of prescription drugs and pharmacy services to DoD healthcare sites nationwide.
Quick answers
Who was awarded contract SPE2DB25FHVQH?
SPE2DB25FHVQH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FHVQH worth?
The government has obligated $4,170 on SPE2DB25FHVQH.
Is contract SPE2DB25FHVQH an order under another contract?
Yes. SPE2DB25FHVQH is a delivery order under SPE2DB24D9230, an indefinite delivery contract.
Was contract SPE2DB25FHVQH competed?
The extent of competition for SPE2DB25FHVQH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award